MENU
NVO
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Novo-Nordisk A/S (NVO) Earnings Date & Reports

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products... Show more

A.I. Advisor
published Earnings

NVO is expected to report earnings to fall 20.31% to 76 cents per share on November 04

Novo-Nordisk A/S NVO Stock Earnings Reports
Q3'26
Est.
$0.76
Q2'26
Beat
by $0.17
Q1'26
Missed
by $0.05
Q4'25
Beat
by $0.10
Q3'25
Missed
by $0.09
The last earnings report on August 04 showed earnings per share of 95 cents, beating the estimate of 78 cents. With 10.26M shares outstanding, the current market capitalization sits at 169.50B.
View a ticker or compare two or three
NVO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry PharmaceuticalsMajor

Industry
Pharmaceuticals Major
Address
Novo Alle 1
Phone
+45 44448888
Employees
69505
Web
https://www.novonordisk.com